| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 14, 2023 |
Director
Trans History: 2
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 250,000 |
| Jun 13, 2023 |
Director
Trans History: 9
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 65,789 | $0.76 | 65,789 |
| May 16, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
| May 16, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,000 | $0.64 | 806,474 |
| May 16, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
| May 12, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 50,141 | $0.66 | 791,474 |
| May 12, 2023 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,496 | $0.66 | 297,842 |
| May 12, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 50,000 | $0.67 | 281,373 |
| Feb 17, 2023 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,025 |
| Feb 15, 2023 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 120,000 | -- | 124,794 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.